DEAN J MITCHELL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEAN J MITCHELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEAN J MITCHELL. DEAN J MITCHELL is President, U.S. Primary Care in BRISTOL MYERS SQUIBB CO ($BMY) and Director in IMMUNOGEN INC ($IMGN) and Director in INTREXON CORP ($XON) and Director in Theravance Biopharma, Inc. ($TBPH) and Director in Kinnate Biopharma Inc. ($KNTE).
Latest Insider Trading Transactions of DEAN J MITCHELL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMY, IMGN, KNTE, XON, TBPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | KNTE | Kinnate Biopharma ... | MITCHELL DEAN J | Director | Option Exercise | A | 24.46 | 20,250 | 495,315 | 20,250 | |
Apr 29 2021 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 20.35 | 6,000 | 122,100 | 6,000 | |
Apr 29 2021 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 9,828 | 0 | 51,034 | 41.2 K to 51 K (+23.85 %) |
Apr 02 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 93,774 | |
Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Grant | A | 7.71 | 7,328 | 56,499 | 177,926 | 170.6 K to 177.9 K (+4.30 %) |
Mar 16 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 62,189 | 0 | 0 | |
Mar 16 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 0.00 | 62,189 | 0 | 170,598 | 108.4 K to 170.6 K (+57.37 %) |
Mar 05 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 5.69 | 2,968 | 16,888 | 0 | |
Mar 05 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 5.69 | 2,968 | 16,888 | 108,409 | 105.4 K to 108.4 K (+2.81 %) |
Jan 04 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,093 | 0 | 92,108 | |
Oct 01 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,750 | 0 | 90,015 | |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,934 | 0 | 86,265 | |
Jun 23 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 3.17 | 2,968 | 9,409 | 0 | |
Jun 23 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 3.17 | 2,968 | 9,409 | 105,441 | 102.5 K to 105.4 K (+2.90 %) |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 83,331 | |
Apr 30 2020 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 30.14 | 6,000 | 180,840 | 6,000 | |
Apr 30 2020 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 6,635 | 0 | 41,206 | 34.6 K to 41.2 K (+19.19 %) |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 66,331 | |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 66,331 | |
Mar 17 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 2.01 | 96,324 | 193,611 | 96,324 | |
Mar 17 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 62,189 | 0 | 62,189 | |
Mar 17 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Grant | A | 2.01 | 28,109 | 56,499 | 102,473 | 74.4 K to 102.5 K (+37.80 %) |
Mar 10 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 24,703 | 0 | 0 | |
Mar 10 2020 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Buy | M | 0.00 | 24,703 | 0 | 74,364 | 49.7 K to 74.4 K (+49.74 %) |
Jan 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,641 | 0 | 62,373 | |
Oct 02 2019 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 59,732 | |
Jul 01 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 6,221 | 0 | 54,154 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 47,933 | |
May 02 2019 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 23.85 | 6,000 | 143,100 | 6,000 | |
May 02 2019 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 8,385 | 0 | 34,571 | 26.2 K to 34.6 K (+32.02 %) |
Apr 01 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 4,981 | 0 | 42,933 | |
Mar 26 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | M | 0.00 | 7,911 | 0 | 0 | |
Mar 26 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Buy | M | 0.00 | 7,911 | 0 | 49,661 | 41.8 K to 49.7 K (+18.95 %) |
Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | M | 3.17 | 8,906 | 28,232 | 0 | |
Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 5.06 | 42,450 | 214,797 | 42,450 | |
Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 24,703 | 0 | 32,614 | |
Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Buy | M | 3.17 | 8,906 | 28,232 | 41,750 | 32.8 K to 41.8 K (+27.12 %) |
Mar 12 2019 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 5.06 | 11,166 | 56,500 | 32,844 | 21.7 K to 32.8 K (+51.51 %) |
Jan 02 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,812 | 0 | 38,952 | |
Oct 01 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,425 | 0 | 36,140 | |
Jul 02 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,387 | 0 | 34,715 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 33,328 | |
May 03 2018 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 8,186 | 0 | 26,186 | 18 K to 26.2 K (+45.48 %) |
Apr 02 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,283 | 0 | 29,328 | |
Mar 29 2018 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 15.80 | 14,246 | 225,087 | 14,246 | |
Mar 29 2018 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 7,911 | 0 | 7,911 | |
Mar 29 2018 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 15.80 | 3,575 | 56,485 | 21,678 | 18.1 K to 21.7 K (+19.75 %) |
Jan 03 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,868 | 0 | 28,045 | |
Oct 03 2017 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,535 | 0 | 26,177 | |
Aug 11 2017 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Buy | P | 18.33 | 5,000 | 91,640 | 18,103 | 13.1 K to 18.1 K (+38.16 %) |
Jul 03 2017 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,652 | 0 | 24,642 | |
Jun 15 2017 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 4.64 | 10,000 | 46,400 | 10,000 | |
Jun 15 2017 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 22,990 | |
May 18 2017 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 6,000 | 0 | 18,000 | 12 K to 18 K (+50.00 %) |
Apr 04 2017 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,036 | 0 | 19,990 | |
Mar 20 2017 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 21.38 | 15,000 | 320,700 | 15,000 | |
Mar 20 2017 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 0.00 | 3,274 | 0 | 13,103 | 9.8 K to 13.1 K (+33.31 %) |
Dec 13 2016 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 1.84 | 5,000 | 9,200 | 5,000 | |
Dec 13 2016 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 16,954 | |
May 05 2016 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
Mar 14 2016 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 34.99 | 15,000 | 524,850 | 15,000 | |
Mar 14 2016 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 34.99 | 2,000 | 69,980 | 9,829 | 7.8 K to 9.8 K (+25.55 %) |
Nov 18 2015 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Buy | P | 12.51 | 10,000 | 125,110 | 10,000 | 0 to 10 K |
Nov 12 2015 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 13.07 | 10,000 | 130,700 | 10,000 | |
Nov 12 2015 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 15,454 | |
Apr 24 2015 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Mar 23 2015 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Option Exercise | A | 47.48 | 15,000 | 712,200 | 15,000 | |
Mar 23 2015 | XON | INTREXON CORP | MITCHELL DEAN J | Director | Grant | A | 47.48 | 1,474 | 69,986 | 7,829 | 6.4 K to 7.8 K (+23.19 %) |
Sep 12 2003 | BMY | BRISTOL MYERS SQUI ... | MITCHELL DEAN J | President, U.S. Pri ... | Grant | A | 0.00 | 10,000 | 0 | 60,000 | 50 K to 60 K (+20.00 %) |
Page: 1